Abstract 86P
Background
MicroRNAs (miRNAs) regulate cancer pathophysiology, promising to diagnose and treat cervical cancer. Recent studies have indicated that miR-205-5p could be a promising biomarker for distinguishing CIN 3 lesions. This study aims to evaluate the impact of miR-205-5p on cervical cancer cells and its interaction with cisplatin-induced apoptosis.
Methods
The expression of MicroRNA-205-5p was assessed using quantitative PCR (qPCR) in a panel of cervical cancer cell lines, compared to the non-tumorigenic epithelial cell line HaCaT. Cells were transfected with anti-miR-205-5p and evaluated for proliferation, migration, invasion, and apoptosis. Apoptosis was assessed in CaSki cells after transfection with anti-miRNA alone or in combination with cisplatin (IC50: 1.05 μg/mL). The transcriptional profile characterization between cells receiving miRNA inhibition versus the negative control was performed using the nCounter PanCancer Progression panel (NanoString Technologies). Subsequently, in silico analyses were conducted to validate potential miR-205-5p targets.
Results
Although anti-miR-205-5p reduced proliferation, migration, and invasion, apoptosis suppression was negligible. However, combining miR-205-5p inhibition with cisplatin significantly increased late apoptosis in CaSki cells, indicating an additive effect. Transcriptional profiling using NanoString revealed three upregulated genes following miR-205-5p inhibition: MGP, MMRN2, and FXYD6, the latter predicted as a target of miR-205-5p. FXYD6 may influence ion transport pathways and HOX gene activation during tumor differentiation, suggesting its role in cervical cancer progression.
Conclusions
This study offers valuable insights into the functional role of miR-205-5p in cervical cancer progression and its potential implications as a biomarker for disease identification and monitoring. The findings suggest a regulatory axis involving miR-205-5p and FXYD6 during cervical cancer progression, as well as a potential mediator biomarker response to cisplatin in cervical cancer cells.
Editorial acknowledgement
Clinical trial identification
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
174P - Human adipose stem cells transfer their mitochondria to breast cancer patient derived organoids increasing drug resistance
Presenter: Martina Marigliano
Session: Cocktail & Poster Display session
Resources:
Abstract
175P - Differential impact of increased neoantigen load on PD-L1 positive immune cell infiltrations in comparison to PD-L1 expression on tumor cells
Presenter: Ashok Kumar Vaid
Session: Cocktail & Poster Display session
Resources:
Abstract
176P - Patient race is a determinant of the impact of Y chromosome loss on survival
Presenter: Suhyeon Choi
Session: Cocktail & Poster Display session
Resources:
Abstract
178P - Clinical correlates and impact of ctDNA levels on detecting distinct genomic alteration in patients with metastatic colorectal cancer
Presenter: Luca Boscolo Bielo
Session: Cocktail & Poster Display session
Resources:
Abstract
179P - Identification of guanine-quadruplex forming DNA aptamer: A promising therapeutic strategy for EGFR overexpressed non-small cell lung cancer
Presenter: Deepa Singh
Session: Cocktail & Poster Display session
Resources:
Abstract
180P - Unravelling drug resistance in high-grade serous ovarian cancer through clonal dynamics and single-cell heterogeneity analysis
Presenter: Alvaro Ingles Russo Garces
Session: Cocktail & Poster Display session
Resources:
Abstract
181P - Establishment of primary prostate cancer patient-derived organoids to assess PARP inhibitors antitumor activity beyond synthetic lethality
Presenter: Tatiana P. Grazioso
Session: Cocktail & Poster Display session
Resources:
Abstract
182P - METHRO: Multicentric study of risk of thrombosis in patients with NSCLC harboring a METexon 14 skipping mutation
Presenter: Maria Virginia Sanchez Becerra
Session: Cocktail & Poster Display session
Resources:
Abstract
183P - SomaVar: A web application for somatic variant storage, annotation and classification
Presenter: Sorin Armeanu-Ebinger
Session: Cocktail & Poster Display session
Resources:
Abstract